The Genotype and Phenotype of Proline-Rich Transmembrane Protein 2 Associated Disorders in Chinese Children
Open Access
- 10 May 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pediatrics
Abstract
Objectives: To study the genetic and clinical characteristics of Chinese children with pathogenic proline-rich transmembrane protein 2 (PRRT2) gene-associated disorders. Methods: Targeted next generation sequencing (NGS) was used to identify pathogenic PRRT2 variations in Chinese children with epilepsy and/or kinesigenic dyskinesia. Patients with confirmed PRRT2-associated disorders were monitored and their clinical data were analyzed. Results: Forty-four patients with pathogenic PRRT2 variants were recruited. Thirty-five of them (79.5%) had heterozygous mutations, including 30 frameshifts, three missenses, one nonsense, and one splice site variant. The c.649dupC was the most common variant (56.8%). Eight patients (18.2%) showed whole gene deletions, and one patient (2.3%) had 16p11.2 microdeletion. Thirty-four cases (97.1%) were inherited and one case (2.9%) was de novo. Forty patients were diagnosed with benign familial infantile epilepsy (BFIE), two patients had paroxysmal kinesigenic dyskinesia (PKD) and two had infantile convulsions and choreoathetosis (ICCA). Patients with whole gene deletions had a later remission than patients with heterozygous mutations (13.9 vs. 7.1 months, P = 0.001). Forty-two patients were treated with antiseizure medications (ASMs). At last follow-up, 35 patients, including one who did not receive therapy, were asymptomatic, and one patient without ASMs died of status epilepticus at 12 months of age. One patient developed autism, and one patient showed mild developmental delay/intellectual disability. Conclusion: Our data suggested that patients with whole gene deletions could have more severe manifestations in PRRT2-associated disorders. Conventional ASMs, especially Oxcarbazepine, showed a good treatment response.This publication has 32 references indexed in Scilit:
- PRRT2 mutation correlated with phenotype of paroxysmal kinesigenic dyskinesia and drug responseNeurology, 2013
- Homozygous c.649dupC mutation in PRRT2 worsens the BFIS/PKD phenotype with mental retardation, episodic ataxia, and absencesEpilepsia, 2012
- PRRT2 phenotypes and penetrance of paroxysmal kinesigenic dyskinesia and infantile convulsionsNeurology, 2012
- PRRT2 Mutations are the major cause of benign familial infantile seizuresHuman Mutation, 2012
- Microdeletions detected using chromosome microarray in children with suspected genetic movement disorders: a single‐centre studyDevelopmental Medicine and Child Neurology, 2012
- Association between Microdeletion and Microduplication at 16p11.2 and AutismThe New England Journal of Medicine, 2008
- Recurrent 16p11.2 microdeletions in autismHuman Molecular Genetics, 2007
- Benign familial infantile seizuresBrain & Development, 2005
- What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?Epilepsy & Behavior, 2004
- Familial Infantile Convulsions and Paroxysmal Choreoathetosis: A New Neurological Syndrome Linked to the Pericentromeric Region of Human Chromosome 16American Journal of Human Genetics, 1997